Detalles de la búsqueda
1.
Computationally restoring the potency of a clinical antibody against Omicron.
Nature
; 629(8013): 878-885, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38720086
2.
The Borrelia hermsii factor H binding protein FhbA is not required for infectivity in mice or for resistance to human complement in vitro.
Infect Immun
; 82(8): 3324-32, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24866803
3.
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants.
bioRxiv
; 2023 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36324800
4.
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics.
PLoS One
; 17(6): e0267796, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657812
5.
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.
Med
; 3(3): 188-203.e4, 2022 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35132398
6.
Genetic transformation of the relapsing fever spirochete Borrelia hermsii: stable integration and expression of green fluorescent protein from linear plasmid 200.
J Bacteriol
; 193(13): 3241-5, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21551306
7.
Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment.
Mol Microbiol
; 76(2): 393-408, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20199597
8.
Complete Genome Sequence of Francisella tularensis Live Vaccine Strain NR-28537 (BEI Master Cell Bank).
Microbiol Resour Announc
; 9(50)2020 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33303672
9.
Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
Vaccine
; 38(8): 1915-1924, 2020 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959423
10.
Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
Vaccine
; 37(17): 2401-2407, 2019 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30922701
11.
The RpoS Gatekeeper in Borrelia burgdorferi: An Invariant Regulatory Scheme That Promotes Spirochete Persistence in Reservoir Hosts and Niche Diversity.
Front Microbiol
; 10: 1923, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31507550
12.
Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model.
Toxins (Basel)
; 11(4)2019 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30959899
13.
Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Vaccine
; 35(24): 3178-3185, 2017 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28479174
14.
Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
Vet J
; 218: 27-33, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27938705
15.
Monoclonal antibody analysis of Perkinsus marinus extracellular products.
Int J Parasitol
; 35(2): 171-84, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15710438
16.
Potential novel epitopes in the extracellular products of oyster homogenate-supplemented Perkinsus marinus cells are not detected by subtractive immunization.
J Parasitol
; 91(3): 689-91, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16108568
17.
The humoral response to in vitro generated parasite antigens is enhanced by the removal of a defined media component prior to immunization.
J Immunol Methods
; 278(1-2): 67-78, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12957397
18.
Assessment of the potential contribution of the highly conserved C-terminal motif (C10) of Borrelia burgdorferi outer surface protein C in transmission and infectivity.
Pathog Dis
; 70(2): 176-84, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24376161
19.
Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate.
Clin Vaccine Immunol
; 18(6): 901-6, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21525304
20.
Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.
Vaccine
; 25(17): 3419-27, 2007 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17239505